PhotoPharmics
photopharmics.com
Actively hiring
Business Development
Health Care
Neurotech & Neuromodulation
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$67.4M
6 rounds on record
Latest round
$6M
Series B · Apr 2025 · 17 mo ago
Team
11-50
employees, estimated range
Backers
2
Kickstart, Park City Angels
The money's age
Due for its next round
17 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 21, 2025
Raised a round Series B $6M
Mar 25, 2024
Launched PhotoPharmics Launches Largest Phototherapy Trial for Parkinson's Disease · businesswire.com
Oct 31, 2023
Raised a round Venture round $26.2M · SEC Form D
Oct 31, 2023
Raised a round Venture round $26.2M · SEC Form D
Aug 31, 2021
New executive PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer · businesswire
Dec 4, 2020
Took on debt financing $2.5M · SEC Form D
Sep 27, 2019
Raised a round Venture round $6.6M · SEC Form D
Jan 31, 2017
Raised a round Venture round $2.3M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Apr 2025 | $6M | — | hitconsultant.net |
| Venture round | Oct 2023 | $26.2M | — | SEC Form D |
| Venture round | Oct 2023 | $26.2M | — | SEC Form D |
| Debt Financing | Dec 2020 | $2.5M | — | SEC Form D |
| Venture round | Sep 2019 | $6.6M | — | SEC Form D |
| Venture round | Jan 2017 | $2.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | PHOTOPHARMICS INC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kent SavageExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Park City Angels Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Welcome to EthosX Finance, your gateway to groundbreaking decentralized finance solutions. Explore our platform for cutting-edge…
Request demo Join our mission Name * Phone number * Email ID * Company Name Company Website Write a message or query Contact us Contact us…
Identify, engage, and retain high-value shoppers with Opensend's lead generation platform. Capture anonymous website visitors, grow email…
Finding a job shouldn't be a full-time job JobStep gets you 5 interviews in 6 weeks by finding and applying to jobs that are great for you…
Does your website already deserve to rank higher in SEO and AI? Get a free 60-second scan from Dash — diib.
Vibiz turns your website or idea into qualified leads. AI-built ad creatives, landing pages, and campaigns across Meta, TikTok, and Google…
Overview
Terms of Use Welcome, and thank you for your interest in PhotoPharmics, Inc. ("PhotoPharmics ", "we", or "us") and our website at www.PhotoPharmics.com (the "Website").
News
PhotoPharmics Completes Pivotal, Phase 3, Light for PD Clinical Trial; to Present Topline Data at World PD Congress
Read more
Report
PhotoPharmics to Participate in AAN Annual Meeting as Phase 3 Light for PD Trial Nears Completion
PhotoPharmics, a clinical-stage medical device company advancing an investigational photo-neuromodulation device for Parkinson's disease, today announced that members of its leadership and clinical team will attend the American Academy of Neurology Annual
Read more
Report
PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company's Phase 3/Pivotal Clinical Trial
PhotoPharmics, Inc. today announced the peer-reviewed publication of results from its Phase 2 randomized, double-blind, controlled clinical trial evaluating Celeste, an investigational photo-neuromodulation device, in people living with Parkinson's diseas
Read more
Report
Understanding Parkinson's Fatigue
Introduction Imagine waking up after a full night's sleep, yet feeling as though you haven't slept in days. Your limbs feel heavy, as if you are moving through molasses, and the mental effort required to simply plan your day feels akin to solving complex
Read more
Report
PhotoPharmics Announces Board Expansion to Support the Next Phases of Growth: Clinical Execution, Commercialization, and Strategic Partnerships
The post PhotoPharmics Announces Board Expansion to Support the Next Phases of Growth: Clinical Execution, Commercialization, and Strategic Partnerships appeared first on PhotoPharmics.
Read more
Report
The Role of Nutrition in Parkinson's Disease
Introduction Did you know that unintentional weight loss and nutritional deficiencies are among the most common challenges for people with Parkinson's disease, often occurring even before a diagnosis is made? In simple terms, Parkinson's Disease is a cond
Read more
Report
Photopharmics Surpasses Enrollment Target With 350 Participants In First-Of-A-Kind Remote"Light For PD" Clinical Trial
Read more
Report
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 "Light for PD" Clinical Trial
PhotoPharmics, a clinical-stage medical device company pioneering Photo Neuromodulation for neurodegenerative disease, today announced it has surpassed its enrollment target with 350 participants in its pivotal, Phase 3 Light for PD clinical trial evaluat
Read more
Report
Young-Onset Parkinson's: Navigating Your Journey After an Early Diagnosis
An early diagnosis of Young-Onset Parkinson's Disease (YOPD) presents a unique set of challenges during the prime of your life. This blog serves as a proactive roadmap for navigating your journey, exploring the differences in YOPD symptoms, modern treatme
Read more
Report
PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson's care PhotoPharmics, a clinical-stage medtech device company specializing in non-invasive photo neurostimulation, today announced its participation in the 2
Read more
Report
Show more news
People
Kent Savage
Executive Officer, Director
Ted Stanley
Director
Gavin Christensen
Director
Daniel Adams
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Highland
United States
HQ
Lehi
United States
Regional office
PHOTOPHARMICS, INC.
3450 North Triumph Boulevard, Suite 141, Lehi, UT 84043 USA
Financials
Total raised
$69.9M
Latest round
Series B
Funding rounds
6